Bosch Health Campus Monthly Research Seminar
This seminar series features prominent speakers related to the various biomedical research foci within the Robert Bosch Gesellschaft für medizinische Forschung (RBMF), Dr. Margarete Fischer-Bosch Institut für Klinische Pharmakologie (IKP), Robert Bosch Centrum für Tumorerkrankungen (RBCT) and the Robert Bosch Centrum für Integrative Medizin und Gesundheit (RBIM).
2026
14.01.2026 Dr. Michael Zimmermann, Head of Metabolomics Core Facility Molecular Systems Biology Unit, EMBL, Heidelberg
Identifying gut microbial contributions to drug metabolism and carcinogen toxicity
23.02.2026 Jun.- Prof. Dr. Nieves Peltzer, Director of the Department Genome Editing, Institute of Biomedical Genetics / RNA Biology & Bioinformatics, University of Stuttgart
Reprogramming Cell Death Pathways to Enhance Anti-Tumor Immunity
02.03.2026 Prof. Shiv K. Singh, Group Leader, Transcriptional Reprogramming in Cancer Plasticity, University Medical Center Göttingen
Emerging Mechanisms of Spatial Tumor Heterogeneity in Pancreatic Cancer
13.04.2026 Prof. Diana Jurk, Senior Associate Consultant II, Associate Professor of Physiology, Department of Physiology and Biomedical Engineering, Department of Neurology, Mayo Clinic, Rochester, USA
Senescence as a driver of age-related cognitive decline: therapeutic opportunities
14.04.2026 Prof. Joao F. Passos, Consultant, Professor of Physiology, Associate Director Robert and Arlene Kogod Center on Aging, Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, USA
Mapping and targeting senescence: harnessing mitochondria to rewire aging
22.04.2026 Prof. Peter Loskill, Professor for Organ-on-Chip Research, Institute of Biomedical Engineering
(IBE), University Hospital Tübingen, Title: Recapitulating Complex Immunocompetent Tissues
using Organ-on-chip and Organoid Technologies
24.04.2026 Prof. Dr. Stefan Schildknecht, Albstadt-Sigmaringen University, Faculty of Life Sciences.
Modulating iron levels: Influence on ferroptotic cell death in neuronal cells
27.05.2026 Prof. Dr. Claudia Löffler, Professor of Integrative Oncological Medicine, Specialist in Internal
Medicine as well as Hematology and Oncology, Senior Physician at theMedical Clinic and
Polyclinic II Würzburg
Whole-Person Cancer Care: Insights From Mind–Body and Exercise Research
01.06.2026 Dr. Moritz Mall, Group Leader, Cell Fate Engineering and Disease Modeling, German Cancer Research Center, DKFZ, Heidelberg
Regulation of cellular plasticity in development and cancer
22.06.2026 Prof. Dr. Wolfgang Sippl, Medicinal Chemistry, Institute of Pharmacy,
Martin-Luther-University Halle-Wittenberg
Development of proteolysis-targeting chimeras (PROTACs) for targeted degradation of
oncologic targets
01.07.2026 Prof. Dr. med. Dr. rer. nat. Ingolf Cascorbi, Director of the Institute of Experimental and
Clinical Pharmacology, University Hospital Schleswig-Holstein
Functional characterization of ABC efflux transporters –genetics, epigenetics and selectivity
27.07.2026 Dr. Nikolaus Dietlein, Postdoc, Cellular Immunology, German Cancer Research Center,
DKFZ, Heidelberg
Title tba
07.09.2026 PD Dr. Philipp Rathert, Lecturer and Group Leader, Institute of Biochemistry,
Department Molecular Biochemistry, University Stuttgart
Title tba
08.09.2026 Dr. Idan Cohen, Assistant Professor in the Department of Microbiology, Immunology
and Genetics, Faculty of Health Sciences, Ben-Gurion University of the Negev, Israel
Title tba
28.09.2026 Dr. med. Florian Perner, Translational Epigenetics, Department of Hematology,
Hemostaseology, Oncology and Cell Therapy, Hannover
Title tba